We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$900M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.35% |
| 2 | Technology | 19% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.89% |
| 5 | Communication Services | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
D.R. Horton
DHI
$39.3B
| $1.05M | ﹤0.01% |
18,979
+10,111
| +114% | +$490K |
|
|
STEX
1227
Streamex Corp
STEX
$74.2M
| $1.05M | ﹤0.01% |
+14,585
| New | +$1.27M |
|
1228
Tesla
TSLA
$1.45T
| $1.05M | ﹤0.01% |
14,595
+9,645
| +195% | +$522K |
|
1229
Enphase Energy
ENPH
$4.76B
| $1.05M | ﹤0.01% |
22,007
+20,456
| +1,319% | +$978K |
|
1230
HealthEquity
HQY
$7.82B
| $1.04M | ﹤0.01% |
17,778
-1,158
| -6% | -$64K |
|
1231
Nektar Therapeutics
NKTR
$2.33B
| $1.04M | ﹤0.01% |
2,998
-5,565
| -65% | -$1.74M |
|
1232
Norfolk Southern
NSC
$71.6B
| $1.04M | ﹤0.01% |
5,922
-22,659
| -79% | -$3.84M |
|
1233
Tyson Foods
TSN
$18.4B
| $1.03M | ﹤0.01% |
17,338
+4,110
| +31% | +$249K |
|
|
TSC
1234
DELISTED
TriState Capital Holdings, Inc.
TSC
| $1.03M | ﹤0.01% |
65,776
-39
| -0.1% | -$530 |
|
|
WCC
1235
WESCO International
WCC
$16.5B
| $1.03M | ﹤0.01% |
29,353
+22,506
| +329% | +$673K |
|
|
ODT
1236
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $1.02M | ﹤0.01% |
+24,175
| New | +$782K |
|
1237
Landstar System
LSTR
$5.81B
| $1.02M | ﹤0.01% |
9,110
-6,832
| -43% | -$730K |
|
|
CIVI
1238
DELISTED
Civitas Resources
CIVI
| $1.02M | ﹤0.01% |
+68,627
| New | +$1.12M |
|
1239
Pixelworks
PXLW
$42M
| $1.02M | ﹤0.01% |
26,203
| – | – |
|
1240
Grand Canyon Education
LOPE
$3.97B
| $1.01M | ﹤0.01% |
11,179
-1,737
| -13% | -$155K |
|
1241
Oshkosh
OSK
$8.95B
| $1.01M | ﹤0.01% |
14,112
-4,042
| -22% | -$276K |
|
1242
PENN Entertainment
PENN
$2.34B
| $1.01M | ﹤0.01% |
33,029
+2,529
| +8% | +$57.9K |
|
1243
Wyndham Hotels & Resorts
WH
$5.13B
| $1.01M | ﹤0.01% |
23,611
+1,345
| +6% | +$54.8K |
|
1244
Deluxe
DLX
$1.1B
| $1M | ﹤0.01% |
42,721
-118,259
| -73% | -$2.96M |
|
1245
State Street Health Care Select Sector SPDR ETF
XLV
$43.8B
| $1M | ﹤0.01% |
10,000
-6,000
| -38% | -$592K |
|
1246
Omnicell
OMCL
$1.49B
| $998K | ﹤0.01% |
14,132
+13,701
| +3,179% | +$938K |
|
1247
Equitable Holdings
EQH
$14.7B
| $995K | ﹤0.01% |
51,580
-8,430
| -14% | -$151K |
|
1248
Southwest Gas
SWX
$6.27B
| $987K | ﹤0.01% |
14,288
-825
| -5% | -$60K |
|
|
HPP
1249
Hudson Pacific Properties
HPP
$630M
| $981K | ﹤0.01% |
+5,572
| New | +$948K |
|
1250
American Financial Group
AFG
$11.8B
| $980K | ﹤0.01% |
15,437
-3,379
| -18% | -$218K |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.